[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Commentary
May 24/31, 2006

Protecting Special Interests in the Name of “Good Science”

Author Affiliations
 

Author Affiliation: UCLA School of Public Health, Los Angeles, Calif.

JAMA. 2006;295(20):2407-2410. doi:10.1001/jama.295.20.2407

Without fanfare or debate, a member of Congress places a rider on the omnibus appropriations bill enacted at the end of the Clinton Administration in late 2000.1 A new 2-sentence law, now known as the Data Quality Act (DQA),2 directs the administration's Office of Management and Budget (OMB) to provide a potent mechanism for interested parties to change the way government agencies review science.3 The full impact of the act is as yet unknown, but it has already resulted in the significant delay of the release and use of valid scientific information. This new tool, to date used primarily by those who have reason to silence or politicize objective scientific research, should be cause for great concern and serious examination.

First Page Preview View Large
First page PDF preview
First page PDF preview
×